Chemfab Alkalis growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−7.0%+2.2%−1.2%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−37.7%−18.9%−51.2%
−116.3%−76.6%−64.0%
+50.6%−126.4%−59.2%
+51.0%−126.2%−59.4%
+10.5%+4.3%+21.4%
−1.2%−1.9%+7.2%
−4.5%−68.4%+36.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CHEMFAB₹293.75

Chemfab Alkalis Limited

· Chemicals
₹ CrorePeersPRIMOPLASTIBLENMANORGKRONOXJAYAGROGNLORDSCHLODMCCSRHHYPOLTDMcap ₹422 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—-1.2+2.2-7.0—
EBITDA Growth—-51.2-18.9-37.7—
EBIT Growth—-64.0-76.6-116.3—
Net Income Growth—-59.2-126.4+50.6—
EPS Growth—-59.4-126.2+51.0—
Total Assets Growth—+21.4+4.3+10.5—
Total Equity Growth—+7.2-1.9-1.2—
Cash from Operations Growth—+36.3-68.4-4.5—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.